secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxxinity, Inc. (—)
CIK:        0001851657
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001562762-23-000353
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 4.01, 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxxinity appoints FORVIS as new auditor; GC departs, new Chief Legal Officer named
--------------------------------------------------------------------------------

- Audit committee appoints FORVIS, LLP as independent auditor effective Sept 27, 2023, replacing Armanino.
- General Counsel René Paula resigns effective Nov 3, 2023 to pursue other opportunities.
- Sumita Ray appointed Chief Legal & Administrative Officer effective Oct 1, 2023.
- Ray brings 20+ years pharma/biotech experience, previously at Pharmacyclics, Calithera, Instil Bio.
- Armanino had resigned citing transition away from public company audits; FORVIS to review Q3 2023 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851657/000156276223000353/0001562762-23-000353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851657/000156276223000353/20230927_8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-23-000353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer